Using technology to enhance Applied Behavior Analysis for children with autism
Evaluating the Effect of Use of Technologies to Increase the Cognitive Abilities in Children With Autism Spectrum Disorders
This study is testing whether using tablets and other technology in therapy can help children with autism learn better and develop important skills compared to traditional therapy methods.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 5 Years to 12 Years |
| Sex | All |
| Sponsor | Istituto per la Ricerca e l'Innovazione Biomedica Academic / other |
| Locations | 1 site (Messina) |
| Trial ID | NCT06310317 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of integrating advanced technologies, such as tablets, into Applied Behavior Analysis (ABA) interventions for children diagnosed with autism spectrum disorder (ASD). The goal is to compare this technology-enhanced approach with traditional ABA methods to determine if it leads to better cognitive skills, new skill acquisition, and functional/adaptive behaviors. The study will involve a control group receiving standard ABA treatment while the experimental group will utilize technology as part of their intervention. The focus is on early and intensive intervention to maximize developmental outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are children diagnosed with autism spectrum disorder.
Not a fit: Patients with other medical disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve learning and behavioral outcomes for children with autism.
How similar studies have performed: While the integration of technology in behavioral interventions is a growing field, this specific approach is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children with diagnosis of autism Exclusion Criteria: * presence of other medical disorders
Where this trial is running
Messina
- Institute for Biomedical Research and Innovation (IRIB) - National Research Council (CNR) — Messina, Italy (Recruiting)
Study contacts
- Principal investigator: Flavia Marino — Institute for Biomedical Research and Innovation (IRIB) - National Research Council (CNR)
- Study coordinator: Flavia Marino
- Email: flavia.marino@irib.cnr.it
- Phone: +393395798263
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.